Physician

Sharad Bajaj, MD

According to 2025 Medicare claims, Sharad Bajaj, MD (NPI: 1497917512) practices cardiology in the Ocala, FL market, with the plurality of this provider's patient population coming from Marion, FL. This provider's primary affiliated billing organization is CARDIOVASCULAR INSTITUTE OF CENTRAL FLORIDA, LLC (NPI: 1679666598; TIN: 20-5476847) and primary practice location at 34476-5575. Bajaj is affiliated with the UnityPoint Accountable Care, L.C. (ACO ID: A5170), participating under the MSSP model.

Bajaj's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,309 traditional Medicare patients, billed 5,371 HCPCS/CPT codes, and received $802,503 in Medicare payments. The top billing code was 99222 (Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes). Part D data shows 4,120 prescription claims across 773 beneficiaries totaling $864,349 in drug costs, led by Eliquis (Apixaban). 2023 DME data shows 12 claims. Open Payments data shows 41 records totaling $1,466. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $19,142 to $864,349. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,113	3,139	$288,031
2016	1,621	6,158	$558,826
2017	1,761	6,432	$540,470
2018	1,682	6,146	$479,463
2019	1,417	5,144	$397,770
2020	1,176	4,753	$373,222
2021	1,254	3,830	$328,251
2022	1,201	4,088	$433,484
2023	1,203	4,711	$569,706
2024	1,309	5,371	$802,503

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	230	685	$19,142
2016	469	3,546	$140,154
2017	641	4,595	$189,288
2018	687	5,382	$347,317
2019	698	5,263	$423,961
2020	702	5,507	$522,467
2021	668	4,514	$466,177
2022	420	1,318	$172,867
2023	411	1,875	$344,113
2024	773	4,120	$864,349

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	13	$23,724
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	12	$23,453
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	222	229	$100
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	396	635	$92
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	535	546	$82
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	219	264	$65
93015	Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician	183	183	$54

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	414	20,337	$388,083
Entresto	Sacubitril/Valsartan	255	10,970	$235,045
Xarelto	Rivaroxaban	76	3,140	$54,601
Farxiga	Dapagliflozin Propanediol	57	2,370	$43,901
Repatha Sureclick	Evolocumab	41	1,652	$31,674

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	41	$1,466	Boston Scientific Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Sharad Bajaj, MD?

Tedicare shows public-source Medicare data for Sharad Bajaj, MD (NPI 1497917512), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Sharad Bajaj, MD have ACO affiliation data?

Sharad Bajaj, MD is shown with ACO affiliation data for UnityPoint Accountable Care, L.C. (MSSP, ACO ID A5170).

What billing organization is linked to Sharad Bajaj, MD?

Sharad Bajaj, MD is linked to CARDIOVASCULAR INSTITUTE OF CENTRAL FLORIDA, LLC (billing NPI 1679666598) in the available physician profile data.

Does Sharad Bajaj, MD have Open Payments data?

Sharad Bajaj, MD has 41 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.